alpha-aminopyridine has been researched along with Nephrotic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kikuchi, D; Okada, K; Takahashi, M; Usui, K; Watanabe, Y | 1 |
1 other study(ies) available for alpha-aminopyridine and Nephrotic Syndrome
Article | Year |
---|---|
The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan.
Topics: Adverse Drug Reaction Reporting Systems; Aminopyridines; Antineoplastic Agents; Dasatinib; Humans; Japan; Lactams; Nephrotic Syndrome; Odds Ratio; Pyrazoles; Risk Factors; Vascular Endothelial Growth Factor A | 2021 |